Pharmacology Final Examination:
2026/2027 Edition||Questions And
Answers With Rationales/Graded
A+/2026 Update/100% Correct
/Instant Download
Institution: Advanced School of Clinical Medicine
Total Questions: 85
Time Allowed: 3 hours
Instructions: Choose the single best answer for each question. Answers and
rationales are provided.
Section A: Pharmacokinetics & Pharmacodynamics (Q1–15)
1. A drug with a half-life of 4 hours is administered intravenously.
Approximately how long will it take to reach 94% of steady-state
concentration?
A. 8 hours
B. 12 hours
C. 20 hours (5 half-lives → 4×5=20)
D. 32 hours
*Rationale: Steady-state is reached after 4–5 half-lives. 5 × 4 = 20 hours.*
2. Which of the following drug properties results in the largest volume of
distribution (Vd)?
A. High plasma protein binding
B. High lipophilicity
C. Low tissue binding
D. High molecular weight
Rationale: Lipophilic drugs cross membranes easily and sequester in tissues,
increasing Vd.
,3. A patient with hepatic cirrhosis shows reduced metabolism of warfarin.
This is due to decreased activity of:
A. CYP2D6
B. CYP2C9
C. CYP3A4
D. CYP1A2
*Rationale: Warfarin is metabolized by CYP2C9 (S-enantiomer). Cirrhosis impairs
CYP2C9 function.*
4. The therapeutic index (TI) is defined as:
A. ED50/TD50
B. TD50/ED50 (for drugs)
C. LD50/ED50 (for safety)
D. ED95/LD5
*Rationale: TI = TD50/ED50 (toxic dose 50%/effective dose 50%). Higher TI =
safer drug.*
5. A drug acting as a full agonist has:
A. Low affinity, high intrinsic activity
B. High affinity, high intrinsic activity
C. Low affinity, zero intrinsic activity
D. High affinity, zero intrinsic activity
Rationale: Agonists require both binding (affinity) and ability to activate receptor.
6. Which CYP enzyme is primarily responsible for metabolizing warfarin’s
more potent S-enantiomer?
A. CYP3A4
B. CYP2C9
C. CYP2D6
D. CYP2E1
Rationale: See Q3 rationale.
7. A patient takes phenytoin and rifampin. The phenytoin level drops. This
interaction is due to:
A. Competitive inhibition
B. Enzyme induction (CYP2C9/2C19)
C. Plasma protein displacement
D. Reduced absorption
, Rationale: Rifampin is a potent inducer of CYP enzymes, increasing phenytoin
metabolism.
8. Zero-order kinetics is best exemplified by:
A. Warfarin at low doses
B. Phenytoin at therapeutic doses
C. Lithium at all doses
D. Digoxin at steady state
Rationale: Phenytoin saturates CYP2C9 at therapeutic levels → constant amount
metabolized per time.
9. The blood-brain barrier (BBB) limits entry of drugs that are:
A. Lipophilic and unionized
B. Hydrophilic or ionized
C. Small molecular weight
D. Actively transported
Rationale: Tight junctions exclude polar/ionized drugs; lipophilic drugs cross
readily.
10. A drug with a high extraction ratio (e.g., propranolol) shows significant:
A. Low first-pass effect
B. High first-pass effect
C. Enterohepatic recirculation
D. Renal excretion
Rationale: High extraction ratio = extensive hepatic metabolism before reaching
systemic circulation.
11. Bioavailability (F) of an oral drug is reduced by all EXCEPT:
A. High first-pass metabolism
B. Efflux by P-glycoprotein
C. High lipid solubility
D. Poor dissolution in gut
Rationale: Lipid solubility enhances absorption, increasing bioavailability.
12. Which of the following is an irreversible antagonist?
A. Atropine (muscarinic)
B. Phenoxybenzamine (α-adrenergic)
C. Naloxone (opioid)
D. Metoprolol (β1)
Rationale: Phenoxybenzamine forms covalent bond with α-receptors.
2026/2027 Edition||Questions And
Answers With Rationales/Graded
A+/2026 Update/100% Correct
/Instant Download
Institution: Advanced School of Clinical Medicine
Total Questions: 85
Time Allowed: 3 hours
Instructions: Choose the single best answer for each question. Answers and
rationales are provided.
Section A: Pharmacokinetics & Pharmacodynamics (Q1–15)
1. A drug with a half-life of 4 hours is administered intravenously.
Approximately how long will it take to reach 94% of steady-state
concentration?
A. 8 hours
B. 12 hours
C. 20 hours (5 half-lives → 4×5=20)
D. 32 hours
*Rationale: Steady-state is reached after 4–5 half-lives. 5 × 4 = 20 hours.*
2. Which of the following drug properties results in the largest volume of
distribution (Vd)?
A. High plasma protein binding
B. High lipophilicity
C. Low tissue binding
D. High molecular weight
Rationale: Lipophilic drugs cross membranes easily and sequester in tissues,
increasing Vd.
,3. A patient with hepatic cirrhosis shows reduced metabolism of warfarin.
This is due to decreased activity of:
A. CYP2D6
B. CYP2C9
C. CYP3A4
D. CYP1A2
*Rationale: Warfarin is metabolized by CYP2C9 (S-enantiomer). Cirrhosis impairs
CYP2C9 function.*
4. The therapeutic index (TI) is defined as:
A. ED50/TD50
B. TD50/ED50 (for drugs)
C. LD50/ED50 (for safety)
D. ED95/LD5
*Rationale: TI = TD50/ED50 (toxic dose 50%/effective dose 50%). Higher TI =
safer drug.*
5. A drug acting as a full agonist has:
A. Low affinity, high intrinsic activity
B. High affinity, high intrinsic activity
C. Low affinity, zero intrinsic activity
D. High affinity, zero intrinsic activity
Rationale: Agonists require both binding (affinity) and ability to activate receptor.
6. Which CYP enzyme is primarily responsible for metabolizing warfarin’s
more potent S-enantiomer?
A. CYP3A4
B. CYP2C9
C. CYP2D6
D. CYP2E1
Rationale: See Q3 rationale.
7. A patient takes phenytoin and rifampin. The phenytoin level drops. This
interaction is due to:
A. Competitive inhibition
B. Enzyme induction (CYP2C9/2C19)
C. Plasma protein displacement
D. Reduced absorption
, Rationale: Rifampin is a potent inducer of CYP enzymes, increasing phenytoin
metabolism.
8. Zero-order kinetics is best exemplified by:
A. Warfarin at low doses
B. Phenytoin at therapeutic doses
C. Lithium at all doses
D. Digoxin at steady state
Rationale: Phenytoin saturates CYP2C9 at therapeutic levels → constant amount
metabolized per time.
9. The blood-brain barrier (BBB) limits entry of drugs that are:
A. Lipophilic and unionized
B. Hydrophilic or ionized
C. Small molecular weight
D. Actively transported
Rationale: Tight junctions exclude polar/ionized drugs; lipophilic drugs cross
readily.
10. A drug with a high extraction ratio (e.g., propranolol) shows significant:
A. Low first-pass effect
B. High first-pass effect
C. Enterohepatic recirculation
D. Renal excretion
Rationale: High extraction ratio = extensive hepatic metabolism before reaching
systemic circulation.
11. Bioavailability (F) of an oral drug is reduced by all EXCEPT:
A. High first-pass metabolism
B. Efflux by P-glycoprotein
C. High lipid solubility
D. Poor dissolution in gut
Rationale: Lipid solubility enhances absorption, increasing bioavailability.
12. Which of the following is an irreversible antagonist?
A. Atropine (muscarinic)
B. Phenoxybenzamine (α-adrenergic)
C. Naloxone (opioid)
D. Metoprolol (β1)
Rationale: Phenoxybenzamine forms covalent bond with α-receptors.
